LungLife AI Past Earnings Performance

Past criteria checks 0/6

LungLife AI has been growing earnings at an average annual rate of 1.8%, while the Biotechs industry saw earnings growing at 11.8% annually. Revenues have been declining at an average rate of 65.1% per year.

Key information

1.8%

Earnings growth rate

62.5%

EPS growth rate

Biotechs Industry Growth11.5%
Revenue growth rate-65.1%
Return on equity-68.4%
Net Margin-11,767.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

Dec 08
We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

Aug 12
We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

Here's Why LungLife AI (LON:LLAI) Must Use Its Cash Wisely

Feb 09
Here's Why LungLife AI (LON:LLAI) Must Use Its Cash Wisely

Here's Why We're A Bit Worried About LungLife AI's (LON:LLAI) Cash Burn Situation

Oct 08
Here's Why We're A Bit Worried About LungLife AI's (LON:LLAI) Cash Burn Situation

Revenue & Expenses Breakdown

How LungLife AI makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:LLAI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-550
30 Sep 230-660
30 Jun 230-660
31 Mar 230-770
31 Dec 220-870
30 Sep 220-780
30 Jun 220-780
31 Mar 220-770
31 Dec 210-760
30 Sep 210-750
30 Jun 210-740
31 Mar 210-630
31 Dec 200-530

Quality Earnings: LLAI is currently unprofitable.

Growing Profit Margin: LLAI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if LLAI's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare LLAI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LLAI is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (3%).


Return on Equity

High ROE: LLAI has a negative Return on Equity (-68.41%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.